Valneva SE (AYJ)
XETR
Closed
Oct 7, 2026
Day's Range
2.5552 wk Range
2.04Overview - AYJ - Valneva SE
Key Statistics
Valuation
Enterprise Value
596.01M
P/E (Trailing)
‪70.97‬
Price / Sales (TTM)
‪3.54‬
Price / Book
‪6.25‬
EV / EBITDA
‪-6.03‬
Profitability
Gross Margin
‪4.57%‬
Profit Margin
‪-110.29%‬
Operating Margin
‪-74.91%‬
Return on Assets
‪-16.68%‬
Return on Equity
‪-117.84%‬
Ownership
Shares Outstanding
204.23M
Float
157.26M
Held by Insiders
‪10.72%‬
Held by Institutions
‪23.91%‬
Price stats
Beta
‪1.37‬
50-Day Avg
‪2.62‬
200-Day Avg
‪3.11‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - AYJ - Valneva SE
Peers - AYJ - Valneva SE
Peer Comparison
Compared with companies in Biotechnology listed on XETR.
- AYJXETRValneva SE504.65MMarket Cap-72.87%52-week change70.98P/E (Trailing)‪-110.29%‬Profit Margin
- ANLXETRAnalog Devices, Inc.166.81BMarket Cap+39.03%52-week change45.97P/E (Trailing)‪29.78%‬Profit Margin
- 0QFXETRModerna Inc.65.00BMarket Cap+87.29%52-week change-22.43P/E (Trailing)‪-141.42%‬Profit Margin
- 22UAXETRBioNTech SE American Depositary Share21.89BMarket Cap+2.60%52-week change157.87P/E (Trailing)‪-63.63%‬Profit Margin
- BBZAXETRBB Biotech AG3.29BMarket Cap+42.63%52-week change13.32P/E (Trailing)‪127.31%‬Profit Margin
- 22ZXETRZealand Pharma A/S2.44BMarket Cap-84.66%52-week change6.85P/E (Trailing)‪59.02%‬Profit Margin
- BV3XETRBavarian Nordic A/S2.18BMarket Cap-8.37%52-week change11.17P/E (Trailing)‪24.33%‬Profit Margin
Profile Summary - AYJ - Valneva SE
About
Valneva SE is a specialty vaccine company headquartered in Saint-Herblain, France, that develops, manufactures, and commercializes prophylactic vaccines targeting infectious diseases with significant unmet medical needs. Its commercial portfolio features three key vaccines: IXIARO®, for Japanese encephalitis;…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
